Federated Hermes
ADVM

Federated Hermes’s Adverum Biotechnologies ADVM Stock Holding History

Federated Hermes’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-490
Closed -$6K – 2137
2022
Q2 		$6K Sell
490
-525
-52% -$5.5K ﹤0.01% 1872
2022
Q1 		$13K Buy
1,015
+462
+84% +$6.76K ﹤0.01% 1864
2021
Q4 		$10K Buy
553
+93
+20% +$1.86K ﹤0.01% 1924
2021
Q3 		$10K Buy
460
+416
+945% +$10.6K ﹤0.01% 1981
2021
Q2 		$2K Buy
+44
New +$2.37K ﹤0.01% 2092
2020
Q4 		– Sell
-8,362
Closed -$861K – 2227
2020
Q3 		$861K Sell
8,362
-14,407
-63% -$2.16M ﹤0.01% 1300
2020
Q2 		$4.75M Buy
+22,769
New +$4.03M 0.01% 731
2019
Q3 		– Sell
-47
Closed -$6K – 2194
2019
Q2 		$6K Buy
+47
New +$3.89K ﹤0.01% 1946
2018
Q3 		– Sell
-115
Closed -$6K – 2245
2018
Q2 		$6K Hold
115
– – ﹤0.01% 1983
2018
Q1 		$7K Sell
115
-126
-52% -$7.84K ﹤0.01% 1918
2017
Q4 		$8K Buy
241
+112
+87% +$3.69K ﹤0.01% 1913
2017
Q3 		$5K Buy
+129
New +$3.58K ﹤0.01% 1947
2015
Q3 		– Sell
-2,000
Closed -$325K – 1973
2015
Q2 		$325K Hold
2,000
– – ﹤0.01% 1421
2015
Q1 		$810K Buy
2,000
+1,000
+100% +$423K ﹤0.01% 1240
2014
Q4 		$540K Sell
1,000
-2,000
-67% -$771K ﹤0.01% 1328
2014
Q3 		$1.03M Buy
+3,000
New +$893K ﹤0.01% 1192

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Federated Hermes's ADVM Position: Q3 2022 in Review

Federated Hermes sold out of Adverum Biotechnologies (ADVM) in Q3 2022, closing a stake of 490 shares — an estimated $6K sold.

Federated Hermes first reported a position in ADVM in Q3 2014 and held it in 16 quarters. The position peaked at $4.75M in Q2 2020. 78 funds tracked by Wall St. Rank hold ADVM as of Q3 2022.

  • Federated Hermes reported no remaining Adverum Biotechnologies position as of Q3 2022 after selling out during the quarter.
  • Federated Hermes sold 490 Adverum Biotechnologies shares in Q3 2022, an estimated $6K.
  • Federated Hermes first reported a position in Adverum Biotechnologies in Q3 2014 and held it in 16 quarters.
  • Federated Hermes's Adverum Biotechnologies position peaked at $4.75M in Q2 2020.
  • 78 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2022.

Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.